Supplementary Fig 4 from TSR-033, a Novel Therapeutic Antibody Targeting LAG-3, Enhances T-Cell Function and the Activity of PD-1 Blockade <i>In Vitro</i> and <i>In Vivo</i>

crossref(2023)

引用 0|浏览9
暂无评分
摘要

TSR-033 shows little to no binding to C1q by ELISA relative to a human IgG1 reference standard

更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要